Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: Clinical importance and proposed accurate investigative tool

Human Reproduction

Volumn 14, Issue 7, 1999, Pages 1903-1907

  Meirow, D ^a   Lewis, H ^b   Nugent, D ^a   Epstein, M ^c  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b MONASH MEDICAL CENTRE   (Australia)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Chemotherapy; Mouse; Ovarian failure; Primordial follicles; Reproduction

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MATING; MENSTRUATION; MOUSE; NONHUMAN; OVARY FOLLICLE; OVARY INSUFFICIENCY; OVULATION; PREGNANCY RATE; REPRODUCTION;

ANIMALIA; FALLOPIA;

EID: 0032772302     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.7.1903     Document Type: Article

References (25)

1. Boring, .C.C. (1994) Cancer statistics 1994. CA Cancer J. Clin., 44, 7-26.
2. Byrne, J., Mulvihill, J.J., Myers, M.H. et al. (1987) Effects of treatment on fertility in Ions-term survivors of childhood of adolescent cancer. N. Engl. J.Med., 317, 1315-1321.
3. Byme, J., Fears, T.R., Gail, M.H. et al. (1992) Early menopause in long-term survivors of cancer during adolescence. Am. J. Obstet. Gynecol., 166, 788-793.
4. Chapman, R.M., Sutcliffe, S.B. and Malpas, J.S. (1979) Cytotoxic-induced ovarian failure in Hodgkin's disease. I. Hormone function. J. Am. Med. Assoc., 242, 1877-1881.
5. Damewood, M.D. and Grochow, L.B. (1986) Prospects for fertility after chemotherapy or radiation foneoplastic disease. Fertil. Steril., 45, 443-459.
6. Familiar!, G., Caggiati, A., Nottola, S.A. et al. (1993) Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease. Hum. Reprod., 8, 2080-2087.
7. Fisher, B. and Cheung, A.Y. (1984) Delayed effect of radiation therapy with or without chemotherapy on ovarian function in women with Hodgkin's disease. Ada Radio!. Oncol., 23, 43-48.
8. Fisher, B., Sherman, B., Rockette, H. et al. (1979) 1-Phenylalanine mustard (L-PAM) in the management of premenopausal patients with primary breast cancer: lack of association of disease-free survival with depression of ovarian function. Cancer, 44, 847-857.
9. Gosden, R.G. and Faddy, M.J. (1994) Ovarian aging, follicular depletion, and steroidogenesis. Exp. Gerontol. 29, 265-274.
10. Gosden, R.G., Wade, J.C., Fraser, H.M. et al. (1997) Impact of congenital hypogonadotropism on the radiation sensitivity of the mouse ovary. Hum. Reprod. 12, 2483-2488.
11. Himelstein-Braw, R., Peters, H. and Faber, M. (1978) Morphological study of the ovaries of leukaemic children. Er. J. Cancer, 38, 82-87.
12. Horning, S.J., Hoppe, R.T., Kaplan, S.H. and Rosenberg, S.A. (198I) Female reproductive potential after treatment for Hodgkin's disease. N. Engl. J. Med., 304, 1377-1382.
13. Koyama, H., Wada, T., Nishizawa, Y. et al. (1977) Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer, 39, 1403-1409.
14. Kuhajda, P.P., Haupt, H.M., Moore, G.W. and Hutchins, G.M. (1982) Gonadal morphology in patients receiving chemotherapy for leukemia. Am. J. Med., 72, 759-767.
15. Kumar, R., Biggart, i.D., McEvoy, J. and McGeowan. M.G. (1972) Cyclophosphamide and reproductive function. Lancet, i, 1212-1214.
16. Marcello, M.F., Nuciforo, G., Romeo, R. et al. (1990) Structural and ultrastructural study of the ovary in childhood leukemia after successful treatment. Cancer, 66, 2099-2104.
17. Meirow, D., Lewin, A., Or, R. etal. (1997a) Ovarian failure post-chemotherapy in young cancer patients - risk assessment indicates the need for intervention. Presented at the 53th American Society for Reproductive Medicine Annual Meeting, Cincinnati, USA. Fertil. Steril Oct, p. S218.
18. Meirow, D., Nugent, D., Livni, N. and Gosden, G. (1997b) The effects of chemotherapy on human primordial follicles an in-vitro study. Presented at the annual meeting of the Israel Fertility Association, Tel-Aviv, May 6, 1997.
19. Nicholson, H.S. and Byrne, J. (1993) Fertility and pregnancy after treatment for cancer during childhood and adolescence. Cancer, 71, 3392-3399.
20. Rose, D.P. and Davis, T.E. (1977) Ovarian function in patients receiving adjuvant chemotherapy for breast cancer. Lancet, i, 1174-1176.
21. Sanders, J.E., Hawley, J., Levy, W. et al. (1996) Pregnancies following high, dose Cyclophosphamide with or without high dose busulfan or total body irradiation and bone marrow transplant. Blood., 87, 3045-3052.
22. Shalet, S.M. (1980) Effects of cancer chemotherapy on gonadal function of patients. Cancer Treat. Rev., 7, 141-152.
23. Uldall, P.R., Kerr, D.N.S. and Tacchi, D. (1972) Sterility and Cyclophosphamide. Lancet, i, 693-694.
24. Wallace, W.H., Shalet, S.M., Tetlow, L.J. and Morris-Jones, P.H. (1993) Ovarian function following the treatment of childhood acute lymphoblastic leukaemia. Med. Pediatr. Oncol, 21, 333-339.
25. Warne, G.L., Fairley, K.F., Hobbs, J.B. and Martin, F.I. (1973) Cyclophosphamide, induced ovarian failure. N. Engl. J. Med., 289, 1159-1162.